Account
Watchlists
Bookmarks
Pricing
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
Bearish
3
Neutral
6
Bullish
5
Bearish
34
Neutral
6
Bullish
6
Bearish
31
Neutral
0
Bullish
1
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Market Cap
₹ 87 Cr
P/E
29.33
Source Natural Foods & Herbal Supplements Limited is a business engaged in the production and sale of allopathic and ayurvedic formulations.
The company focuses deeply on R&D to diversify its product portfolio, especially in creating herbal and organic nutritional supplements.
Its key products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets, aiming to integrate Ayurveda into daily diets.
Despite operational challenges, such as factory shutdowns due to insufficient working capital, the company revived under new management focusing on high-quality Ayurveda products.
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
87 Cr
Low Risk
29.3
30.8
4.8
3.7
223.85
118.95
Sales CAGR
1Y
64.54%
3Y
27.79%
5Y
24.35%
10Y
15.95%
Profit CAGR
1Y
66.67%
3Y
6.08%
5Y
12.11%
10Y
23.75%
ROE
TTM
12.56%
3Y
11.36%
5Y
14.24%
10Y
14.05%
ROCE
TTM
15.10%
3Y
17.32%
5Y
20.45%
10Y
18.88%
Performance
STEADY PERFORMER
Valuation
OVERVALUED
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Bearish
Risk
MODERATE RISK
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
90.85 | 101 Cr | 14.87 | 2.24 | 0.00 | 19.50 | 25.71 | 15.37 | |
61.35 | 97 Cr | — | 2.06 | 0.00 | -9.29 | -5.26 | -5.27 | |
118.20 | 96 Cr | 17.83 | 2.55 | 0.00 | 0.00 | 0.00 | 0.00 | |
86.97 | 94 Cr | 9.45 | 2.15 | 0.00 | 22.69 | 25.33 | 9.83 | |
88.00 | 88 Cr | 151.60 | 2.55 | 0.00 | 1.67 | 6.00 | 0.85 | |
137.95 | 87 Cr | 29.33 | 3.68 | 0.00 | 12.56 | 15.10 | 7.35 | |
37.50 | 75 Cr | 7.00 | 1.08 | 0.00 | 11.07 | 11.52 | 10.35 |
